A Randomized Controlled Trial of Multimodality Therapy in the Treatment of Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
- 30 Jul 2010 Biomarkers information updated
- 07 Apr 2009 Planned end date changed from 1 Oct 2008 to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 13 Aug 2007 New trial record.